Isn't that an assumption you are making in the absence of having seen the CRL?
Nope, it is based on fact. Fact that came directly from the mouth of Dr Krause, who has read the actual the CRL, and who said:
"one of the significant positive indicators from the CRL - is that the CRL did not question the efficacy of the product as demonstrated in GvHD001, (which was the case for the previous CRL )"
I am actually quite shocked that either you have not listened to the webcast, or you ignored what he said?
Maybe this is easier.... Isn't it an assumption you are making that the potency assay has not been validated, in the absence of seeing the CRL?
Can you reference any commentary from MSB following CRL2 that specifically says the potency assay is not valid, or remains to be validated?
Krause then goes on to say
" BUT The CRL did continue to raise questions about the potency assay, specifically the characterisation and standardisation of the product that went into GvHD001 and the ability to make future product that is similar to that which went into GvHD001. This leaves open the real possibility that by using exactly the same assays that were used to characterise the product that went into the GvHD001 trial, for new commercial product, that it would be possible to show that the new commercial product is similar enough to that which was effective in GvHD001. "
Nowhere was FDA questioning the efficacy
Nowhere was FDA stating the potency assays were inadequate
- Forums
- ASX - By Stock
- MSB
- 2023 Next Steps
2023 Next Steps, page-152
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.0¢ |
Change
-0.015(1.55%) |
Mkt cap ! $1.084B |
Open | High | Low | Value | Volume |
96.5¢ | 96.5¢ | 94.5¢ | $2.433M | 2.552M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 72431 | 94.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.0¢ | 20225 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 72431 | 0.945 |
6 | 52140 | 0.940 |
8 | 92185 | 0.935 |
5 | 73150 | 0.930 |
4 | 51132 | 0.925 |
Price($) | Vol. | No. |
---|---|---|
0.950 | 20225 | 5 |
0.955 | 42472 | 3 |
0.960 | 80775 | 4 |
0.965 | 57967 | 5 |
0.970 | 73641 | 5 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online